Abiopharma

🔍 Shulman Joseph (Executive)

Company: RHYTHM PHARMACEUTICALS, INC. (RYTM)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Acquired 2,024 shares of Common Stock at $6.8 per share (Direct)
  Date: 2026-08-13 | Code: M | equity_swap_involved: 0 | shares_owned_after: 20,994.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 5,079 shares of Common Stock at $119.75 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 15,915.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,024 shares of Stock Options (Right to Buy) at $6.8 per share (Derivative)
  Date: 2026-08-13 | Code: M | Expires: 2032-02-08 | equity_swap_involved: 0 | shares_owned_after: 5,945.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The Exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.
• F2: The stock options were granted on February 9, 2022. The options vested and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.